Anthem

RANK50

America’s largest for-profit health insurance federation continues to roll on unabated, and, as with other industry titans, vertical integration has been its key to success in a tumultuous year. Controlling the length of a supply chain provides a bit of security in uncertain times, and Anthem’s pharmacy benefits arm IngenioRx has helped it do just that. The company’s 2020 revenue was just shy of $121 billion, a 17% increase over the previous year, assisted by a massive surge in Anthem’s Medicare Advantage business. The unit encompassing IngenioRx helped fuel a 9.3% year-over-year spike in first-quarter 2021 sales and is one of the company’s main focus areas going forward.